1. Home
  2. ABTS vs ALBT Comparison

ABTS vs ALBT Comparison

Compare ABTS & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABTS
  • ALBT
  • Stock Information
  • Founded
  • ABTS 2010
  • ALBT 2014
  • Country
  • ABTS Hong Kong
  • ALBT United States
  • Employees
  • ABTS N/A
  • ALBT N/A
  • Industry
  • ABTS Computer Software: Programming Data Processing
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ABTS Technology
  • ALBT Health Care
  • Exchange
  • ABTS Nasdaq
  • ALBT Nasdaq
  • Market Cap
  • ABTS 8.9M
  • ALBT 7.4M
  • IPO Year
  • ABTS N/A
  • ALBT N/A
  • Fundamental
  • Price
  • ABTS $3.48
  • ALBT $2.33
  • Analyst Decision
  • ABTS
  • ALBT
  • Analyst Count
  • ABTS 0
  • ALBT 0
  • Target Price
  • ABTS N/A
  • ALBT N/A
  • AVG Volume (30 Days)
  • ABTS 8.7K
  • ALBT 64.7K
  • Earning Date
  • ABTS 08-13-2025
  • ALBT 08-14-2025
  • Dividend Yield
  • ABTS N/A
  • ALBT N/A
  • EPS Growth
  • ABTS N/A
  • ALBT N/A
  • EPS
  • ABTS N/A
  • ALBT N/A
  • Revenue
  • ABTS $7,037,156.00
  • ALBT $1,159,091.00
  • Revenue This Year
  • ABTS N/A
  • ALBT N/A
  • Revenue Next Year
  • ABTS N/A
  • ALBT N/A
  • P/E Ratio
  • ABTS N/A
  • ALBT N/A
  • Revenue Growth
  • ABTS 31.69
  • ALBT N/A
  • 52 Week Low
  • ABTS $1.35
  • ALBT $1.87
  • 52 Week High
  • ABTS $14.10
  • ALBT $11.66
  • Technical
  • Relative Strength Index (RSI)
  • ABTS 38.61
  • ALBT 54.34
  • Support Level
  • ABTS $3.40
  • ALBT $2.04
  • Resistance Level
  • ABTS $3.89
  • ALBT $2.19
  • Average True Range (ATR)
  • ABTS 0.25
  • ALBT 0.14
  • MACD
  • ABTS -0.03
  • ALBT 0.04
  • Stochastic Oscillator
  • ABTS 9.54
  • ALBT 95.48

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: